Health

Ministry of Health signs contract with Korean company for oncology center in Tashkent

Illustration: Tezkun / AI. Not a photograph of the event.

The Ministry of Health of Uzbekistan has signed a contract with the South Korean company AUM & LEE Architects & Associates to consult on the implementation of a 265-bed oncology center project in the capital.

The Ministry of Health of Uzbekistan has signed a contract with the South Korean company AUM & LEE Architects & Associates to consult on the implementation of a 265-bed oncology center project in the capital. This was reported by the press service of the Ministry of Health.

The document was signed by the head of the ministry, Eldor Adilov, and the company's vice president, Lee Won Sok. During the meeting, the parties discussed the further stages of work. The new center will be part of a medical cluster being formed in Tashkent with the participation of the Korea Export-Import Bank.

The AUM & LEE consortium will be responsible for consulting on the design of the building, construction management and control, as well as the selection of medical equipment. The consultations will also cover the planning of medical services and the center's information system.

The staff of the future institution will undergo practical training in three stages. The program will cover the quality of medical care, radiology, nuclear medicine, and radiation therapy.

"For us, it is important to build a center with high quality. We trust the experience and quality of the Korean side," the press service quotes the minister as saying.

What it means

An oncology center with 265 beds is planned to be built in Tashkent. The Korean company will consult on the project from design to equipment selection, and the center's staff will undergo training in three stages on the quality of medical care, radiology, nuclear medicine, and radiation therapy.

Published 24 October 2026, 15:16 · No updates · Russian original

Discussion
  1. Loading comments…
No links or insults. One comment per 20 seconds.

Comments on this story live under its post in our Telegram channel. Comment on Telegram